FDA Approves GenePOC C. Diff Test
The FDA clears the molecular test in the US to detect presence of the toxin within 70 minutes.
Read More
Boomers, Millennials Affected the Most by Opioid Epidemic
While the abuse level has leveled off, overdose deaths continue to climb.
Higher Brain Glucose Levels Indicate Severe Alzheimer's
Greater reductions in brain glycolysis demonstrated a relationship to symptoms of Alzheimer’s disease like memory problems.
FDA Approves First Implanted Lens That Can Adjust After Cataract Surgery
Adjustments of the artificial lens allows patients to have better vision when not utilizing glasses.
FDA Approves First Two-Drug Regimen for HIV
Juluca is the first complete treatment regimen containing only 2-drugs, instead of 3 or more in standard treatment.
FDA Grants Lofexidine Priority Review for Opioid Withdrawal Treatment
This would be the first and only non-opioid, non-addictive medication for management of opioid withdrawal.
FDA Approves AUVI-Q for Infants and Small Children
The first and only epinephrine auto-injector is approved specifically for infants and children.
New Survey Reveals Impact BV Has on Women
It sheds light on greater education needs about a gynecologic infection that impacts 1 in 3 women.
FDA Approves First Telehealth Option for Cochlear Implants
The option to program cochlear implants remotely can greatly reduce the burden for patients and families.
FDA Advisory Committee Advises Against Ciprofloxacin DPI
The committee warns against the approval due to inconsistent data, concerns about drug resistance and lack of endpoints met.
Nathan Radcliffe, MD: New Surgical Instrument Allows for Simultaneous Cataract and Glaucoma Surgery
Kahook Dual Blade intends to reduce intraocular pressure and the number of patient medications.
John Shepherd, MD: Recognizing and Addressing Depression in Low Vision Patients
Depression has been shown in research studies to correlate with the level of disability.
Carl Awh, MD: Human Experience of Hypersonic Vitrectomy
This new technology allows for smaller gauge with flow rate similar to that of the guillotine-based one.
Jason Slakter, MD: Unmet Needs in Wet AMD
Squalamine lactate, a topical eye drop, is studied as an add-on to anti-VEGF therapy to improve visual function.
Jason Slakter, MD: Squalamine Lactate Eye Drops in Wet AMD
The multi-targeted inhibitor, a non-invasive eye drop, acts in a different way of treating the chronic disease.
Peter Andreas Netland, MD, PhD: How to Detect Uveitis
The diagnostics of the disease is not only important for the initial evaluation, but also etiology and long-term management.
Peter Andreas Netland, MD, PhD: Uveitis and Glaucoma Prevalence Rates
As new diagnoses appear, etiology is understood better and treated better, resulting in a decrease of prevalence rates.
Correlation Between CRA, Volume of SRF in NVAMD
A study shows CRA presence has a negative correlation with the volume of SRF.
FDA Accepts IDP-118 NDA for Plaque Psoriasis
If approved, this will be the first and only topical lotion that contains a unique combination formula.
FDA Panel Recommends CAM2038 in Opioid Use Disorder
In 2016, roughly 11.6 million adults misused opioids in the US, yet only 1.1 million received medication-assisted therapy.
Brexpiprazole Phase 3 Trials Initiated for Bipolar Treatment
Two phase 3 clinical trials begin enrollment for treatment of manic episodes associated with bipolar I disorder.
AbbVie Announces Positive Elagolix Phase 3 Data
In 2 extension studies, no new safety concerns were identified for the 12-month treatment period.
FDA Advisory Committee Recommends RBP-6000 For Opioid Use
If approved, this will be the first monthly injectable buprenorphine treatment for opioid use disorder.
Phase 3 LATUDA Data Demonstrates Bipolar Depression Symptom Improvement
Positive results showed 6 weeks of treatment associated with significant improvement of depressive symptoms in children and adolescents.
FDA Approves New 10 mg Dosing for XARELTO
Rivaroxaban is the only Factor Xa inhibitor demonstrating superior efficacy in reducing recurrent VTE after initial treatment.
Dr. Aaron Brault, PhD: Sexual Transmission of Zika Through Animal Models
An arbovirologist discusses what animal models tell us about the sexual transmission of Zika virus.
HIV Vaccine Needed to End Pandemic
NIAID emphasizes importance of an effective HIV vaccine to achieve a durable end to the HIV/AIDS pandemic.
FDA Grants Priority Review to Elagolix
If approved, elagolix will be the first new oral medication treatment option in more than a decade.
NIH Completes Atlas Detailing Human DNA
The catalog is critical in how individual genomic variation leads to biological differences, especially in the context of disease.
Plazomicin Submitted for NDA in Treatment of Complicated UTI
The drug has the potential to treat certain multi-drug resistant gram-negative pathogens like CRE.